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This year, the recipients of the Lasker Award for Basic
Medical Research are Ernest A. McCulloch and James
E. Till. The landmark studies of McCulloch and Till in
the 1960s defined the hallmark properties of stem
cells: the ability to self-renew and differentiate.
Not a week goes by that the scientific community or the
media fails to report on stem cells. The topic is being
discussed in the Congress of the United States as well
as in governmental bodies around the globe. The fund-
ing of stem cell institutes by state governments and
private benefactors is considered daily. How did we get
there? The revolution began almost 50 years ago with
the fundamental studies of two Canadian scientists, Dr.
Ernest A. McCulloch and Dr. James E. Till. The pioneer-
ing work of McCulloch and Till now has been recog-
nized by the Lasker Foundation, with their receipt of
the 2005 Lasker Award for Basic Medical Research. The
landmark studies of McCulloch and Till in the 1960s
defined the hallmark properties of stem cells: the ability
to self-renew and differentiate. Working with mouse
bone marrow cells, McCulloch and Till developed an
assay to quantitate a class of early blood-forming pro-
genitor cells and to define the potential of these cells
both to self-renew and to undergo extensive differentia-
tion into many different blood cell types. Stem cells are
very difficult to study due to their rarity (that is, 1 in
10,000 bone marrow cells in the mouse). In addition,
their quiescent nature diminishes the ability to obtain a
complete stem cell phenotype or “footprint” to aid in
their identification and purification.
In the Beginning
From 1960 to 1963, McCulloch and Till demonstrated
that cells residing in the mouse bone marrow, upon
transplantation to a heavily irradiated mouse recipient,
migrate to the spleen and form discrete colonies (nod-
ules) (McCulloch and Till, 1960; Becker et al., 1963).
Within the nodules, they identified donor cells belong-
ing to several hematopoietic lineages. They used ab-
normal chromosome marker studies to establish the
clonal nature of the nodules. The authors concluded
that these nodules represented the progeny of single
transplanted bone marrow cells based upon the direct
linear relationship between the number of cells trans-
planted and the number of colonies observed. They
demonstrated that the cells within the colony could
give rise to additional colonies after serial transplanta-
tion into secondary recipient mice, the now classic as-*Correspondence: ssharkis@jhmi.edusay for self-renewal potential. They also realized that
the nodules on the surface of the spleen—which they
called colony-forming units-spleen (CFU-S)—had vari-
able capacity for self-renewal, suggesting a functional
heterogeneity within the population. This heterogeneity
has led to the concept that not all stem cells are cre-
ated equal, even though stem cells as a class are the
most primitive cells within a tissue and provide the or-
gan with a renewable source of differentiated progeny.
During the next decade, assays for more mature clono-
genic progenitor cells of bone marrow grown in vitro
were developed. A hierarchy was established and as
these cells differentiated they were shown to lose the
self-renewal potential characteristic of the earliest cells
in the stem cell compartment. The observed hetero-
geneity also implied that regulation of clonal expansion
may be stochastic. These basic tenets of stem cell biol-
ogy, namely, that the stem cell must demonstrate both
self-renewal and differentiation potential, have remained
both conceptually and practically the same even given
the decades of additional research to understand how
stem cells maintain homeostasis of the organism.
Controversies in the Field
It was nearly 30 years after the discovery of CFU-S by
McCulloch and Till that bone marrow hematopoietic
stem cells (HSCs) were isolated successfully, enabling
HSCs to be studied directly rather than through colony-
forming assays. Yet this delay did not deter McCulloch
and Till, their colleagues, and their students from con-
tinuing to establish the fundamental physiological roles
of HSCs and hematopoietic progenitor cells. They real-
ized that the clonogenic assays, although quantitative,
did not directly measure the engraftment potential of
the stem cell. The colony assay for CFU-S, although
providing an observable window on the potential of
mouse HSCs in the short term (that is, 1 to 2 weeks
post-transplant), did not establish the potential of these
cells for long-term engraftment. Other groups set out
to identify the external factors that influenced the self-
renewal and differentiation of HSCs. Identification of
new growth factors suggested extrinsic regulation
rather than intrinsic control of stem cell properties. As
scientists discovered these growth factors, they began
to argue against the stochastic hypothesis of clonal ex-
pansion of stem cells. They developed an alternative
deterministic hypothesis: that HSC renewal and differ-
entiation were regulated by the external microenviron-
ment. These two opposing arguments, heated at times,
have been at least partially reconciled by recognition
that the clonal expansion and regulated differentiation
of HSCs both contribute to long-term engraftment of
donor HSCs in recipient bone marrow. However, each
hypothesis will be challenged over and over again, as
they have been most recently with studies showing the
conversion of HSCs into cells of other tissues.
Finally, a long-term reconstituting cell population
containing CFU-S was isolated in 1988, described in
the classical paper by Irving Weissman’s group (Span-
Cell
818grude et al., 1988). Now the long-term reconstituting
cell could be studied directly. Through proof-of-prin-
ciple experiments, scientists could examine the self-
renewal and long-term reconstituting capacity of HSCs
that heretofore were measurable only indirectly by the
colony assay developed by McCulloch and Till decades
earlier. Several different isolation technologies were de-
veloped for HSCs based on function and phenotype.
Our group showed (Jones et al., 1990) that CFU-S, al-
though multipotent, did not copurify with the long-term
reconstituting cell. Then the hierarchy of HSCs was ex-
panded yet again: into early and later stem cells, com-
mitted early and later progenitors, and fully differenti-
ated cells.
One can reason that the earliest stem cell in develop-
ment is the zygote. Clearly the fertilized egg has a po-
tential for differentiation (pluripotency) that far exceeds
that of any adult tissue. Embryonic stem cell lines, both
mouse and human, exhibit both self-renewal and ex-
tensive differentiation capacity in vitro. However, one of
the questions under great debate, both by scientists
and by political groups worldwide, is the question of
whether stem cells in the adult retain their capacity for
self-renewal and pluripotency? These studies have led
to the concept of stem cell plasticity. Once again the
biological principles set forth by the studies of McCul-
loch and Till in the early 1960s prove relevant. These
early studies required transplantation of clonogenic
HSCs to obtain successful engraftment and rescue of
the irradiated mouse recipients. Studies in the 1960s
and 1970s demonstrated functional repair of injured
bone marrow by the stem cells. Parallel studies of pluri-
potency today also need to demonstrate functional re-
pair of injured tissues (heart, lung, liver, etc.). Do the
injury signals (that is, the microenvironmental factors
produced by the injury) directly regulate HSC differenti-
ation or is repair by HSCs a random event? This ques-
tion remains the subject of ongoing experiments by
many different groups.
Therapy: Then and Now
In the 1960s and 1970s, in the middle of a cold war and
during a heightened nuclear threat, it was prudent for
the military to consider the effects of ionizing radiation
on soldiers. Research on treating lethal irradiation by
bone marrow transplantation was militarily justifiable and
sponsored. These sponsored basic research studies of
McCulloch and Till were complemented by the initiation
of therapeutic intervention protocols at several medical
institutions. Transplantation of bone marrow cells to
treat bone marrow failure caused by, for example,
aplastic anemia or hematological malignancy became
the treatment of choice for otherwise fatal diseases.
Additional sources of enriched HSCs were sought be-
cause within the bone marrow these stem cells are rare.
Subsequently, both umbilical cord blood and mobilized
peripheral blood were found to be enriched sources of
HSCs. These sources were tested for their ability to
provide rapid and durable engraftment of bone marrow,
once again adhering to the criteria established by the
studies in animals of McCulloch and Till and their col-
leagues in the 1960s. Umbilical cord blood contains
more long-term engrafting HSCs than bone marrow, but
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s limited.
Let us fast forward to the late 1990s to look at addi-
ional sources of stem cells. Human embryonic stem
ell lines have been established in vitro. The ability to
row pluripotent human embryonic stem cells in vitro
ight provide an inexhaustible source of stem cells for
herapeutic and research purposes. Early experiments
ave shown that cell lines derived from human embryos
ay have both unlimited self-renewal capacity and dif-
erentiation potential. The implications and promise for
herapy have become enormous. We are at the begin-
ing of developing research approaches to use this
ource of stem cells to benefit humanity, but the chal-
enges are formidable. We should apply the same strin-
ent biological principles to characterize human and
ouse embryonic stem cells that McCulloch and Till
sed to successfully characterize the HSCs of mouse
one marrow 45 years ago: Do they self-renew and dif-
erentiate extensively as measured by serial transplan-
ation and long-term reconstitution?
Many researchers continue to observe in animals that
one marrow cells in general and in some cases a mar-
ow population enriched for stem cells can repair many
ypes of injured tissues. Thus, bone marrow cells ap-
ear to be remarkably plastic, transforming into cells of
he liver, lung, and brain upon transplantation into in-
ured recipients. Of particular note, in an animal model
f myocardial infarction (Orlic et al., 2001), the direct
njection into heart muscle of a stem cell enriched pop-
lation from bone marrow or mobilized peripheral blood
SCs resulted in an improvement in cardiac muscle
unction. This has led to clinical trials in patients with
eart disease with early results showing some improve-
ent. Whether this is really plasticity remains a matter
f debate, but importantly, these studies have led to
he identification of cardiac stem cells that may be use-
ul for therapy in the future. Scientists are now search-
ng for stem cell populations in many different tissues
oping that their isolation will lead to a therapeutic ap-
roach for regenerative medicine.
ancer Stem Cells
fter establishing the basic tenets of stem cell biology,
cCulloch and Till turned their attention to leukemia.
rom the late 1970s until today, the Toronto group has
een instrumental in comparing the properties of nor-
al stem cells with those of malignant cells. They pre-
icted that in acute myelogenous leukemia the culprit
as abnormal gene expression rather than a block in
ifferentiation. They found that in myeloid cell lines self-
enewal could be equated with immortality and sug-
ested that determination of differentiation in leukemia
as promiscuous. This infidelity could be a result of
enetic reprogramming similar to the plasticity that has
ost recently been observed with normal stem cells.
s a result of these studies, the concept evolved that
ithin a tumor there is a small population of initiating
ells that are now termed cancer stem cells. Currently,
his concept is under intense investigation. Solid tu-
ors of tissues such as breast and lung are being ex-
mined to identify this rare cell type. It is hoped that
emoval of this initiating cell by selective destruction
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819will lead to more efficacious therapies. Once again,
characterization of the proliferative and differentiation
capacities of these abnormal stem cells follows the bio-
logical properties outlined by those earlier pioneering
studies of McCulloch and Till.
Concluding Remarks
The importance of stem cell biology should not be un-
derestimated given the potential for these cells to repair
injured tissues, to become the target for destruction
following malignant transformation, and to allow us to
understand genetic and epigenetic changes during cel-
lular proliferation and differentiation. Forty-five years
ago, two basic scientists found nodules on the spleen
of irradiated rodents transplanted with donor bone
marrow. These nodules represented for the first time
the clonal expansion of a stem cell. The cell itself would
be difficult to capture, but McCulloch and Till devel-
oped an assay to study its behavior. When new stu-
dents join my lab, I insist that they set up a spleen col-
ony assay. The assay teaches techniques such as
intravenous injection and sterile handling of bone mar-
row cells. It also shows reproducibly the clonal nature
of stem cells as the students carry out the same cell
dose-response curve for injected bone marrow cells
that McCulloch and Till used to so elegantly show that
the number of spleen colonies is directly proportional
to the number of bone marrow cells injected.
I can think of no more deserving a team for the
Lasker award than that of Earnest McCulloch and
James Till, whose revolutionary studies ignited the field
of stem cell biology so many years ago.
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